https://www.selleckchem.com/products/c381.html
40. 95% CI -3.03-3.83, P = 0.82), postoperative complications (RR 1.41. 95% CI 0.76-2.63, P = 0.28), or recurrence (RR 2.33, 95% CI 0.48-11.44, P = 0.3. SG for RGC tended to be correlated with favorable 5-year overall survival; however, the association was not statistically significant (HR 0.89, 95% CI 0.63-1.26, P = 0.51). Organ-preserving approaches such as SG may be a safe and feasible treatment option for early-stage RGC. Organ-preserving approaches such as SG may be a safe and feasible treatment option for early-stage RGC.The mechan
Like
Comment
Share
